Interim results on European multi-center trial to evaluate the clinical utility of arteriovenous fistulae for treatment of severe COPD

A. Jerrentrup, M. Wagner, J. Ficker, H. Teschler, H. Wirtz, S. Lang, S. Blaas, J. Steier, J. Bräunlich, C. Vogelmeier (Marburg, , Essen, Leipzig, Gera, Donaustauf, Germany)

Source: Annual Congress 2010 - Interventions for obstructive lung diseases
Session: Interventions for obstructive lung diseases
Session type: Oral Presentation
Number: 3419
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Jerrentrup, M. Wagner, J. Ficker, H. Teschler, H. Wirtz, S. Lang, S. Blaas, J. Steier, J. Bräunlich, C. Vogelmeier (Marburg, , Essen, Leipzig, Gera, Donaustauf, Germany). Interim results on European multi-center trial to evaluate the clinical utility of arteriovenous fistulae for treatment of severe COPD. Eur Respir J 2010; 36: Suppl. 54, 3419

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Update on the European multicenter, blinded and randomized study of bronchoscopic placement of valves for the treatment of severe emphysema
Source: Annual Congress 2008 - New trends in interventional pulmonology
Year: 2008


The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results.
Source: International Congress 2017 – Interventional pulmonology highlights 2017
Year: 2017




European multicenter, blinded and randomized study design to evaluate the effectiveness of bronchoscopic airway valve placement for the treatment of advanced emphysema
Source: Annual Congress 2007 - Interventional bronchoscopy
Year: 2007


Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Year: 2021



Quality of diffusion measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


LATE-BREAKING ABSTRACT: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the spiration valve system intra-bronchial therapy for severe emphysema
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016


Effectiveness of the tromboembolic venous disease treatments estimated through clinical trials vs. observational studies
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019

Patients in randomized clinical trials of bronchiectasis are only partially representative of clinical practice: A European cohort study
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

International multicenter trial of bronchial valve treatment for severe emphysema
Source: Eur Respir J 2007; 30: Suppl. 51, 711s
Year: 2007

A multicentre observational study of the prevalence, management and outcomes of subsegmental pulmonary embolism
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial
Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Year: 2020




An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Lung volume reduction coil treatment for patients with severe heterogeneous emphysema, a multicenter feasibility trial
Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope?
Year: 2011

A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019
Year: 2019



Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Quality of forced spirometry in a worldwide multicenter clinical trial with moderate to severe COPD patients with emphysema
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021



Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
Source: ERJ Open Res, 8 (1) 00552-2021; 10.1183/23120541.00552-2021
Year: 2022